FAKTOR-OPTIONSSCHEIN - CARL ZEISS MEDITEC Share Price

Certificat

DE000MF8TLW2

Market Closed - Bid/Ask 17:50:50 19/06/2024 BST After market 19:40:32
0.75 EUR -5.06% Intraday chart for FAKTOR-OPTIONSSCHEIN - CARL ZEISS MEDITEC 0.75 0.00%
Current month-63.43%
1 month-74.52%
Date Price Change
19/06/24 0.75 -5.06%
18/06/24 0.79 -5.95%
17/06/24 0.84 -59.81%
14/06/24 2.09 +1.46%
13/06/24 2.06 -6.79%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 05:50 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
Issuer Morgan Stanley
WKN MF8TLW
ISINDE000MF8TLW2
Date issued 07/12/2018
Strike 44.27
Maturity Unlimited
Parity 28.26 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 103.7
Lowest since issue 0.75
Spread 0.02
Spread %2.63%

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
66.4 EUR
Average target price
91.6 EUR
Spread / Average Target
+37.95%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW